bioaccess® is the clinical research CRO in Panama for first-in-human device work: Miami headquarters, in-country operations, and the MINSA file — Decreto 21 ethics clocks, the device channel, and a 6–8 week first-patient planning clock. We run trials there.
bioaccess® is the CRO in Panama and CRO en Panamá for first-in-human device work. Miami headquarters. MINSA (Ministerio de Salud) and CNBI (Comité Nacional de Bioética de la Investigación) are the authorities on the file. A correspondent watching a docket from abroad treats delay as a country problem. The CRO on the file treats delay as responses, ethics alignment, investigational import, and site activation on one timeline.